obstructive sleep apnea – Asian Pacific Journal of Allergy and Immunology

April 23, 2023

The use of topical nasal steroids to improve continuous positive airway pressure compliance in patients with obstructive sleep apnea: An updated systematic review and meta-analysis of randomized control trials

Nasal steroids are commonly prescribed to reduce nasal side effects, which are the primary cause of continuous positive airway pressure (CPAP) intolerance in obstructive sleep apnea (OSA) patients.

July 7, 2021

Nocturnal asthma

Nocturnal asthma has unique pathophysiological mechanisms, comorbid diseases, and intervention. Even though the treatments for asthma have been highly developed, there are a high number of patients with asthma whose symptoms are not well controlled, particularly those with nocturnal asthma in which symptoms occur during the night and interfere with sleep.

circadian, gastroesophageal reflux disease, inflammatory processes, nocturnal asthma, obstructive sleep apnea

June 15, 2020

A randomized, double-blind, placebo-controlled trial on the effect of intranasal corticosteroid as a treatment for moderate to severe obstructive sleep apnea with coexisting chronic rhinitis

Chronic rhinitis is a common co-existing disease with obstructive sleep apnea (OSA). Current evidence on intranasal steroid efficacy as a treatment modality is scarce.

chronic rhinitis, intranasal corticosteroid, obstructive sleep apnea, oral appliance, positional therapy

March 19, 2020

The prevalence of high risk of obstructive sleep apnea in patients with allergic rhinitis

Although allergic rhinitis (AR) has not been acknowledged as a strong risk factor for obstructive sleep apnea (OSA), several pathophysiological linkages between these two conditions have frequently been reported. However, epidemiological data relating to the prevalence of OSA in patients with AR remain scarce.

Allergic rhinitis, obstructive sleep apnea, snoring, STOP-Bang, Thai